Aura Biosciences (AURA) Net Cash Flow Growth (1y) (2021 - 2026)
Aura Biosciences (AURA) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 301.06% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | 286.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 286.10% |
| Dec 31, 2025 | 93.51% |
| Sep 30, 2025 | -1,181.06% |
| Jun 30, 2025 | 1,721.18% |
| Mar 31, 2025 | 144.27% |
| Dec 31, 2024 | 143.29% |
| Sep 30, 2024 | -159.45% |
| Jun 30, 2024 | -58.92% |
| Mar 31, 2024 | 82.18% |
| Dec 31, 2023 | -124.08% |
| Sep 30, 2023 | 7.71% |
| Jun 30, 2023 | 117.19% |
| Mar 31, 2023 | -104.25% |
| Dec 31, 2022 | -10.30% |
| Sep 30, 2022 | 170.24% |
| Jun 30, 2022 | -625.02% |
| Mar 31, 2022 | -149.44% |
| Dec 31, 2021 | 5,304.90% |